Therefore, we may presume that KISS1, KISS1R, MMP-2, and MMP-9 can be used for the diagnostic, assessment of the progression of endometriosis and the effectiveness of treatment of this disease in women from 23 to 38 years old without endocrine system pathology and oncology diseases. This evidence concerns the gene MMP9 and endometriosis.